Showing results (161-170 of 588) with videos related to
Sort By:
Pageof 59
Cancer|May 13, 2008
Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trialsFederica Cuppone, Emilio Bria, Paolo Carlini, et al.Cancer Treatment Reviews|August 22, 2006
Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trialsEmilio Bria, Federica Cuppone, Mariangela Ciccarese, et al.Cancer Treatment Reviews|August 27, 2018
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysisRoberto Iacovelli, Chiara Ciccarese, Emilio Bria, et al.Critical Reviews in Oncology/Hematology|May 22, 2019
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisionsRoberto Iacovelli, Chiara Ciccarese, Giovanni Schinzari, et al.Cancer|May 2, 2006
Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patientsEmilio Bria, Cecilia Nistico, Federica Cuppone, et al.European Journal of Cancer (Oxford, England : 1990)|October 26, 2005
Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patientsCarlo Garufi, Barbara Vanni, Anna Maria Aschelter, et al.Journal of Thoracic Disease|June 29, 2018
Do immune checkpoint inhibitors need new studies methodology?Roberto Ferrara, Sara Pilotto, Mario Caccese, et al.Anti-Cancer Drugs|November 1, 2006
Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factorsCecilia Nisticò, Federica Cuppone, Emilio Bria, et al.Cancer Chemotherapy and Pharmacology|June 19, 2014
Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariatesDan Lu, Sandhya Girish, Yuying Gao, et al.Cancer Genetics and Cytogenetics|June 2, 2010
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignanciesGiovanni Ponti, Gabriele Luppi, Francesca Giacobbi, et al.Pageof 59